(Q46822732)

25 December 2017

title

Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence (English)

1 reference

25 December 2017

0 references

1 reference

8

Ryffel B

1 reference

25 December 2017

Dambuza I

1

1 reference

25 December 2017

Allie N

2

1 reference

25 December 2017

Fick L

3

1 reference

25 December 2017

Johnston N

4

1 reference

25 December 2017

Fremond C

5

1 reference

25 December 2017

Mitchell J

6

1 reference

25 December 2017

Quesniaux VF

7

1 reference

25 December 2017

Jacobs M

9

1 reference

25 December 2017

publication date

22 October 2007

1 reference

25 December 2017

published in

Tuberculosis

1 reference

25 December 2017

volume

88

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

221-234

1 reference

25 December 2017

A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Association of an HLA-DQ allele with clinical tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

TNF-blocking agents and tuberculosis: new drugs illuminate an old topic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

The TNF and TNF receptor superfamilies: integrating mammalian biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Tumor necrosis factor signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Membrane TNF confers protection to acute mycobacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Characterization of tumor necrosis factor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Increased resistance to mycobacterial infection in the absence of interleukin-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Identification of nitric oxide synthase as a protective locus against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Membrane tumor necrosis factor confers partial protection to Listeria infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Lethal Granuloma Disintegration in Mycobacteria-Infected TNFRp55-/- Mice Is Dependent on T Cells and IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Reactivation of latent tuberculosis infection in TNF-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Disseminated tuberculosis in interferon gamma gene-disrupted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Interleukin-10 and the interleukin-10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Interferon-gamma gene expression during acute graft-versus-host disease: relationship to MHC induction and tissue injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.08.011

10.1016/J.TUBE.2007.08.011

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

17950671

1 reference

25 December 2017